FdaApplication

ANDA 207209

Back to search

Identifiers

Properties

PropertyValue
applicant_nameMACLEODS PHARMACEUTICALS LTD
application_typeANDA
approval_date2023-03-22

Products (3)

ProductActive ingredientStrengthDosage form
REPAGLINIDEREPAGLINIDE1MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE0.5MGTABLET;ORAL
REPAGLINIDEREPAGLINIDE2MGTABLET;ORAL

3 products